ANTI-EGFR ANTIBODY DRUG CONJUGATES

Abstract: the invention relates to anti-epidermal growth factor receptor (egfr) antibody drug conjugates (adcs) which inhibit bcl-xl, including compositions and methods of using said adcs.

Inventor(s): Erwin R. BOGHAERT, Milan BRUNCKO, Andrew S. JUDD, Andrew C. PHILLIPS, Andrew J. SOUERS

CPC Classification: A61K39/39591 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250213685